Primary or concurrent carcinoma-in-situ of the urinary bladder

Active Ingredient: BCG vaccine

Indication for BCG vaccine

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

1 instillation every week for 6 weeks and thereafter 1 instillation weekly for 3 weeks at months 3, 6, and 12

For:

Dosage regimens

Regimen A: Urethral, 50 milliliters bCG vaccine, once weekly, over the duration of 6 weeks.

Regimen B: Urethral, 50 milliliters bCG vaccine, once weekly, over the duration of 3 weeks.

Detailed description

Induction treatment

Weekly instillation during the first 6 weeks.

Maintenance treatment

Maintenance treatment consists of weekly instillation with BCG vaccine during 3 consecutive weeks at months 3, 6, and 12 after initiation of the treatment. The need for maintenance treatment every 6 months beyond the first year of treatment should be evaluated on the basis of tumour classification and clinical response.

Dosage considerations

Insert a catheter via the urethra into the bladder and drain the bladder completely.

Connect the syringe containing the prepared BCG suspension to the catheter and instil the suspension into the bladder. If a closed-system transfer device is not available, the suspension is instilled into the bladder by gravity flow. After instillation, remove the catheter.

The instilled suspension must remain in the bladder for a period of 2 hours. During this period care should be taken that the instilled suspension has sufficient contact with the whole mucosal surface of the bladder. Therefore, the patient should not be immobilised or, in case of a bed-ridden patient, should be turned over from back to abdomen and vice versa every 15 minutes. After two hours, have the patient void the instilled suspension in a sitting position.

Urine should be voided in a sitting position for 6 hours after treatment and two cups of household bleach should be added to the toilet before flushing. The bleach and urine should be left to stand in the toilet for 15 minutes before flushing.

NOTE: The patient must not ingest any fluid for a period starting 4 hours prior to instillation, until bladder evacuation is permitted (i.e. 2 hours after instillation).

Active ingredient

BCG vaccine

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known.

Read more about BCG vaccine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.